Latvian health authorities temporarily suspend the use of the Oxford–AstraZeneca vaccine as a precaution following reports of blood clot issues among vaccinated people.
The Indonesian Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting WHO review amid reports of blood clot cases among the vaccinated people in several European countries.
The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaiting WHO review amid reports of blood clot cases among the vaccinated people in several European countries.
PortugueseDirectorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as aprecaution following reports of "rare,butserious" side-effects among vaccinated people.
The Ministry of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine while awaitingWHOreviewamidst reports of bloodclotcases amongst vaccinated peopleinseveralEuropeancountries.
Slovenia suspends the use of the Oxford–AstraZeneca vaccine as aprecaution following reports of blood clot cases among vaccinated people.
ThePortugueseDirectorate-GeneralofHealthtemporarilysuspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of "rare,butserious" side-effects among vaccinated people.
Latvianhealthauthorities temporarilysuspends temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of bloodclot issues among vaccinated people.
Latvian health authorities temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precaution following reports of blood clot issues among vaccinated people.
Germany,Italy,France,andSpain suspend the use of the Oxford–AstraZeneca vaccine following reports of blood clots.
Slovenia suspends the use of the Oxford–AstraZeneca vaccine asaprecautionfollowing reports of casesofblood clotsinvaccinatedpeopleinothercountries.
TheMinistryofHealthtemporarilysuspends the use of the Oxford–AstraZeneca vaccine while awaitingaWHOreviewamidst reports of cases of blood clots in vaccinated people fromseveralEuropean countries.
The Directorate-General of Health temporarily suspends the use of the Oxford–AstraZeneca vaccine as a precautionfollowing reports of "rare, butsevere"suspected side-effects among vaccinated people in other countries.
Latvianhealth authorities temporarily suspend the use of the Oxford–AstraZeneca vaccine as a precaution following reports of bloodclot issues among vaccinated people.